Prognostic value of biochemical Markers in Ischaemic Heart Disease

Authors: A Betriu
A Burlina
A Hirayama
A Maseri
A Maseri
AB Wu
AB Wu
AH Kragel
AM Hutter Jr
AM Miltenburg Van
B Cummins
B Cummins
B Lindahl
B Phibbs
BJ Gersh
BL Huey
C Lame
CA Clyne
CR Conti
CT Sherman
CW Hamm
CW Hamm
DG Rizik
E Braunwald
E Braunwald
E Falk
E Falk
E Hoberg
E Swahn
E Thaulow
EM Antman
EM Ohman
EM Ohman
Fibrinolytic Therapy Trialists’ Collaborative Group
GS Bodor
GV Heller
H Tunstall
HA Katus
HA Katus
HA Katus
HA Katus
HA Katus
HE Botker
HG Olson
I Nyman
I Wilcox
II Adams
J Granborg
J Launbjerg
J Lindenfeld
J Mair
J Markenvard
J Ravkilde
J Ravkilde
J Ravkilde
J Ravkilde
J Rawles
J Ross Jr
JA Ambrose
JA Ambrose
JA Ambrose
JA Cairns
JB Herrick
JE Adams
JJ Fenton
JK Madsen
JM Vreede de
JS Schroeder
K Gotoh
K Mizuno
M Galvani
M Herder
M Müller-Bardorff
MA Dewood
MA Pfeffer
ME Dorogy
MI Davies
MJ Davies
MJ Davies
MJ Davies
MJ Mcqueen
MK Heng
ML Simoons
MS Löscher
P Constantinides
P Nicod
P Stubbs
P Stubbs
PA Merlini
PC Gazes
PG Hugenholz
PJ Feyter de
PO Collinson
PW Armstrong
R Gorlin
R Mulcahy
R Nordlander
RA Hong
RB Allison
RD White
RJ Winter de
RW Harper
S Kano
S Sclarovsky
S Yusuf
SA Levine
SO Gottlieb
T Pettersson
TH Lee
The GUSTO Investigators
TT Bashour
TX O’Brien
U Piran
V Fuster
V Fuster
V Fuster
VV Murthy
W Gerhardt
WB Kannel
Y Seino
ZG Turi
Publication date: 1 January 1998
Publisher: 'Springer Science and Business Media LLC'
Doi

Abstract

Abstract is not available.

Similar works

Full text

thumbnail-image

Available Versions

Crossref

redirect

info:doi/10.1007%2F978-94-017-...

Last time updated on 22/07/2021